Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Hsiang Lo

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Head & Neck|January 18, 2014
Subsequent risk of nasopharyngeal carcinoma among patients with allergic rhinitis: a nationwide population-based cohort studyKuen-Tze Lin, Wen-Yen Huang, Che-Chen Lin, et al.
Plos One|May 26, 2017
Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapyCheng-Hsiang Lo, Jen-Fu Yang, Ming-Yueh Liu, et al.
Radiation Oncology (London, England)|October 24, 2019
Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysisJen-Fu Yang, Cheng-Hsiang Lo, Meei-Shyuan Lee, et al.
BMC Cancer|August 22, 2021
Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast CancerYang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, et al.
NPJ Genomic Medicine|June 3, 2021
Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapyYang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, et al.
European Journal of Gastroenterology & Hepatology|January 4, 2014
Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolizationCheng-Hsiang Lo, Wen-Yen Huang, Meei-Shyuan Lee, et al.
Scientific Reports|October 4, 2019
Prognostic Significance of Apparent Diffusion Coefficient in Hepatocellular Carcinoma Patients treated with Stereotactic Ablative RadiotherapyCheng-Hsiang Lo, Wen-Yen Huang, Chih-Weim Hsiang, et al.
Clinical Breast Cancer|March 23, 2025
Primary Stereotactic Body Radiation Therapy for Breast Cancer Spinal MetastasesKuan-Nien Chou, David J Park, Yusuke S Hori, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular CarcinomaPo-Chien Shen, Wei-Chou Chang, Cheng-Hsiang Lo, et al.
Journal of the Chinese Medical Association : JCMA|February 13, 2022
Combination therapy of sorafenib and drug-eluting bead transarterial chemoembolization for advanced hepatocellular carcinoma with and without hepatic arteriovenous shuntPin-Ko Chen, Sung-Hua Chiu, Ming-Ting Tsai, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Head & Neck|January 18, 2014
Subsequent risk of nasopharyngeal carcinoma among patients with allergic rhinitis: a nationwide population-based cohort studyKuen-Tze Lin, Wen-Yen Huang, Che-Chen Lin, et al.
Plos One|May 26, 2017
Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapyCheng-Hsiang Lo, Jen-Fu Yang, Ming-Yueh Liu, et al.
Radiation Oncology (London, England)|October 24, 2019
Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysisJen-Fu Yang, Cheng-Hsiang Lo, Meei-Shyuan Lee, et al.
BMC Cancer|August 22, 2021
Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast CancerYang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, et al.
NPJ Genomic Medicine|June 3, 2021
Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapyYang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, et al.
European Journal of Gastroenterology & Hepatology|January 4, 2014
Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolizationCheng-Hsiang Lo, Wen-Yen Huang, Meei-Shyuan Lee, et al.
Scientific Reports|October 4, 2019
Prognostic Significance of Apparent Diffusion Coefficient in Hepatocellular Carcinoma Patients treated with Stereotactic Ablative RadiotherapyCheng-Hsiang Lo, Wen-Yen Huang, Chih-Weim Hsiang, et al.
Clinical Breast Cancer|March 23, 2025
Primary Stereotactic Body Radiation Therapy for Breast Cancer Spinal MetastasesKuan-Nien Chou, David J Park, Yusuke S Hori, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular CarcinomaPo-Chien Shen, Wei-Chou Chang, Cheng-Hsiang Lo, et al.
Journal of the Chinese Medical Association : JCMA|February 13, 2022
Combination therapy of sorafenib and drug-eluting bead transarterial chemoembolization for advanced hepatocellular carcinoma with and without hepatic arteriovenous shuntPin-Ko Chen, Sung-Hua Chiu, Ming-Ting Tsai, et al.
Pageof 4